668 related articles for article (PubMed ID: 15787829)
21. [Generalized chromomycosis caused by Phialophora verrucosa].
Radouane N; Hali F; Khadir K; Soussi M; Ouakadi A; Marouane S; Zamiati S; Benchikhi H
Ann Dermatol Venereol; 2013 Mar; 140(3):197-201. PubMed ID: 23466152
[TBL] [Abstract][Full Text] [Related]
22. Chromoblastomycosis.
Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
[TBL] [Abstract][Full Text] [Related]
23. Chromoblastomycosis: clinical presentation and management.
Ameen M
Clin Exp Dermatol; 2009 Dec; 34(8):849-54. PubMed ID: 19575735
[TBL] [Abstract][Full Text] [Related]
24. Case report: Fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: Disseminated chromoblastomycosis caused by phialophora.
Qiu Y; Zhang J; Tang Y; Zhong X; Deng J
J Infect Chemother; 2019 Dec; 25(12):1031-1036. PubMed ID: 31229375
[TBL] [Abstract][Full Text] [Related]
25. Atypical eumycetoma caused by Phialophora parasitica successfully treated with itraconazole and flucytosine.
Hood SV; Moore CB; Cheesbrough JS; Mene A; Denning DW
Br J Dermatol; 1997 Jun; 136(6):953-6. PubMed ID: 9217835
[TBL] [Abstract][Full Text] [Related]
26. [Case of chromomycosis due to the species Phialophora compacta newly isolated in the USSR].
Timokhovskiĭ IuA
Vestn Dermatol Venerol; 1983 Jun; (6):23-5. PubMed ID: 6225263
[No Abstract] [Full Text] [Related]
27. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
[TBL] [Abstract][Full Text] [Related]
28. Chromoblastomycosis caused by Phialophora verrucosa on the hand.
Takeuchi A; Anzawa K; Mochizuki T; Takehara K; Hamaguchi Y
Eur J Dermatol; 2015; 25(3):274-5. PubMed ID: 26066414
[No Abstract] [Full Text] [Related]
29. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
Xibao Z; Changxing L; Quan L; Yuqing H
J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous localized annular chromoblastomycosis.
Salgado CG; da Silva MB; Yamano SS; Salgado UI; Diniz JA; da Silva JP
J Cutan Pathol; 2009 Feb; 36(2):257-61. PubMed ID: 18727664
[TBL] [Abstract][Full Text] [Related]
31. Treatment of cryptococcal meningitis with triple combination of amphotericin B, flucytosine and itraconazole.
Chotmongkol V; Jitpimolmard S
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):381-3. PubMed ID: 8629082
[No Abstract] [Full Text] [Related]
32. Chromoblastomycosis associated with Fonsecaea pedrosoi in a carpenter handling exotic woods.
Menezes N; Varela P; Furtado A; Couceiro A; Calheiros I; Rosado L; Mota G; Baptista A
Dermatol Online J; 2008 Feb; 14(2):9. PubMed ID: 18700112
[TBL] [Abstract][Full Text] [Related]
33. Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis.
Hayakawa M; Ghosn EE; da Gloria Teixeria de Sousa M; Ferreira KS; Almeida SR
Scand J Immunol; 2006 Oct; 64(4):382-7. PubMed ID: 16970678
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi.
Coelho RA; Almeida-Silva F; Figueiredo-Carvalho MHG; Rabello VBS; de Souza GR; Lourenço MCDS; Rodrigues ML; Almeida-Paes R
Med Mycol; 2024 Mar; 62(4):. PubMed ID: 38533658
[TBL] [Abstract][Full Text] [Related]
35. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B.
Poirriez J; Breuillard F; Francois N; Fruit J; Sendid B; Gross S; Dei-Cas E
Am J Trop Med Hyg; 2000; 63(1-2):61-3. PubMed ID: 11357997
[TBL] [Abstract][Full Text] [Related]
36. [Chromomycosis].
Cachão P; Rocha MM; Cabrita J; Rodrigo JG
Med Cutan Ibero Lat Am; 1987; 15(5):403-6. PubMed ID: 3325708
[TBL] [Abstract][Full Text] [Related]
37. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous fungal infection caused by Fusarium solani.
Yao Z; Liao W; Li Z; Xu H
Chin Med J (Engl); 1998 Nov; 111(11):1054-6. PubMed ID: 11189218
[No Abstract] [Full Text] [Related]
39. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of skin test for chromoblastomycosis using antigens prepared from culture filtrates of Fonsecaea pedrosoi, Phialophora verrucosa, Wangiella dermatitidis and Exophiala jeanselmei.
Iwatsu T; Miyaji M; Taguchi H; Okamoto S
Mycopathologia; 1982 Jan; 77(1):59-64. PubMed ID: 7070478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
